Bilcare Limited (BOM:526853)
66.33
-0.50 (-0.75%)
At close: Feb 12, 2026
Bilcare Market Cap
Bilcare has a market cap or net worth of 1.51 billion as of February 13, 2026. Its market cap has decreased by -10.52% in one year.
Market Cap
1.51B
Enterprise Value
8.81B
Revenue
7.57B
Ranking
n/a
PE Ratio
n/a
Stock Price
66.33
Market Cap Chart
Since December 17, 2003, Bilcare's market cap has increased from 1.11B to 1.51B, an increase of 36.58%. That is a compound annual growth rate of 1.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 1.51B | -19.27% |
| Dec 31, 2025 | 1.88B | 21.50% |
| Dec 31, 2024 | 1.54B | -17.03% |
| Dec 29, 2023 | 1.86B | 107.97% |
| Dec 30, 2022 | 894.72M | -54.38% |
| Dec 31, 2021 | 1.96B | 91.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oxygenta Pharmaceutical | 2.17B |
| Quest Laboratories | 2.12B |
| Ambalal Sarabhai Enterprises | 2.00B |
| Aayush Wellness | 1.80B |
| Coral Laboratories | 1.75B |
| Astonea Labs | 1.68B |
| Pharmaids Pharmaceuticals | 1.37B |
| Sotac Pharmaceuticals | 1.37B |